Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Ueda

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Physiological Reports|March 5, 2022
Physiological role of anticipatory cardiorespiratory responses to exerciseTadayoshi Miyamoto, Daisuke Sotobayashi, Go Ito, et al.
Cancer Science|March 21, 2019
Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumorsYutaka Fujiwara, Haruo Iguchi, Noboru Yamamoto, et al.
Plant & Cell Physiology|June 3, 2017
Cytochrome P450 Monooxygenase CYP716A141 is a Unique b-Amyrin C-16b Oxidase Involved in Triterpenoid Saponin Biosynthesis in Platycodon grandiflorusKeita Tamura, Yuga Teranishi, Shinya Ueda, et al.
Anticancer Research|March 10, 2015
Circulating hepatocyte growth factor is correlated with resistance to cetuximab in metastatic colorectal cancerKimio Yonesaka, Taroh Satoh, Shinya Ueda, et al.
Diabetes, Obesity & Metabolism|December 1, 2018
Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetesHirotaka Watada, Masanari Shiramoto, Shinya Ueda, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2013
A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumorsWataru Okamoto, Takayuki Yoshino, Toshiaki Takahashi, et al.
Oncotarget|November 9, 2017
Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancerHiroto Ueda, Masayuki Takeda, Shinya Ueda, et al.
Japanese Journal of Clinical Oncology|February 9, 2021
Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancerKensei Yamaguchi, Nozomu Fuse, Yoshito Komatsu, et al.
The Oncologist|June 7, 2022
Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant MesotheliomaYutaka Fujiwara, Yasuo Takahashi, Morihito Okada, et al.
The Oncologist|May 25, 2012
Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapyTakahiro Tsushima, Masataka Taguri, Yoshitaka Honma, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Physiological Reports|March 5, 2022
Physiological role of anticipatory cardiorespiratory responses to exerciseTadayoshi Miyamoto, Daisuke Sotobayashi, Go Ito, et al.
Cancer Science|March 21, 2019
Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumorsYutaka Fujiwara, Haruo Iguchi, Noboru Yamamoto, et al.
Plant & Cell Physiology|June 3, 2017
Cytochrome P450 Monooxygenase CYP716A141 is a Unique b-Amyrin C-16b Oxidase Involved in Triterpenoid Saponin Biosynthesis in Platycodon grandiflorusKeita Tamura, Yuga Teranishi, Shinya Ueda, et al.
Anticancer Research|March 10, 2015
Circulating hepatocyte growth factor is correlated with resistance to cetuximab in metastatic colorectal cancerKimio Yonesaka, Taroh Satoh, Shinya Ueda, et al.
Diabetes, Obesity & Metabolism|December 1, 2018
Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetesHirotaka Watada, Masanari Shiramoto, Shinya Ueda, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2013
A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumorsWataru Okamoto, Takayuki Yoshino, Toshiaki Takahashi, et al.
Oncotarget|November 9, 2017
Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancerHiroto Ueda, Masayuki Takeda, Shinya Ueda, et al.
Japanese Journal of Clinical Oncology|February 9, 2021
Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancerKensei Yamaguchi, Nozomu Fuse, Yoshito Komatsu, et al.
The Oncologist|June 7, 2022
Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant MesotheliomaYutaka Fujiwara, Yasuo Takahashi, Morihito Okada, et al.
The Oncologist|May 25, 2012
Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapyTakahiro Tsushima, Masataka Taguri, Yoshitaka Honma, et al.
Pageof 6